Liquidia Corporation (NASDAQ:LQDA – Get Free Report) insider Jason Adair sold 688 shares of the firm’s stock in a transaction on Monday, October 26th. The shares were sold at an average price of $43.19, for a total value of $29,714.72. Following the completion of the sale, the insider owned 177,269 shares in the company, valued at $7,656,248.11. The trade was a 0.39% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Jason Adair also recently made the following trade(s):
- On Monday, October 12th, Jason Adair sold 7,301 shares of Liquidia stock. The stock was sold at an average price of $28.48, for a total transaction of $207,932.48.
- On Friday, August 21st, Jason Adair sold 73,631 shares of Liquidia stock. The stock was sold at an average price of $69.09, for a total transaction of $5,087,165.79.
Liquidia Stock Performance
Shares of LQDA stock traded up $0.28 during trading hours on Wednesday, reaching $45.72. The stock had a trading volume of 2,235,400 shares, compared to its average volume of 2,280,838. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.31 and a quick ratio of 2.12. Liquidia Corporation has a twelve month low of $22.05 and a twelve month high of $93.61. The firm has a 50-day simple moving average of $54.69 and a 200-day simple moving average of $54.15. The firm has a market capitalization of $4.09 billion, a PE ratio of 33.37, a price-to-earnings-growth ratio of 0.37 and a beta of 0.61.
Liquidia (NASDAQ:LQDA – Get Free Report) last posted its earnings results on Wednesday, August 12th. The company reported $0.74 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.76 by ($0.02). Liquidia had a net margin of 30.74% and a return on equity of 149.65%. The firm had revenue of $171.68 million for the quarter, compared to analyst estimates of $168.48 million. During the same period in the previous year, the firm earned ($0.49) earnings per share. The company’s revenue for the quarter was up 1842.1% on a year-over-year basis. As a group, equities analysts forecast that Liquidia Corporation will post 2.05 earnings per share for the current year.
Institutional Trading of Liquidia
Hedge funds and other institutional investors have recently made changes to their positions in the stock. Pinnacle Wealth Planning Services Inc. lifted its stake in shares of Liquidia by 26.2% in the 3rd quarter. Pinnacle Wealth Planning Services Inc. now owns 1,557 shares of the company’s stock worth $47,000 after acquiring an additional 323 shares during the period. Sterling Capital Management LLC lifted its position in Liquidia by 839.1% in the third quarter. Sterling Capital Management LLC now owns 2,329 shares of the company’s stock worth $70,000 after purchasing an additional 2,081 shares during the period. Nisa Investment Advisors LLC boosted its stake in Liquidia by 13.8% during the 3rd quarter. Nisa Investment Advisors LLC now owns 2,634 shares of the company’s stock valued at $80,000 after purchasing an additional 320 shares in the last quarter. Globeflex Capital L P bought a new position in Liquidia during the 2nd quarter valued at $175,000. Finally, Nykredit A S acquired a new position in shares of Liquidia during the 2nd quarter valued at $177,000. 64.54% of the stock is currently owned by institutional investors.
Analyst Ratings Changes
Several equities analysts have recently issued reports on LQDA shares. HC Wainwright boosted their price objective on Liquidia from $58.00 to $65.00 and gave the stock a “buy” rating in a research report on Thursday, October 15th. Wall Street Zen cut Liquidia from a “buy” rating to a “hold” rating in a research report on Saturday, October 3rd. Needham & Company LLC cut their target price on Liquidia from $72.00 to $58.00 and set a “buy” rating on the stock in a research note on Wednesday, October 14th. Jefferies Financial Group upgraded Liquidia to a “strong-buy” rating in a research report on Thursday, October 1st. Finally, Piper Sandler set a $129.00 price target on Liquidia in a research note on Friday, July 24th. One equities research analyst has rated the stock with a Strong Buy rating, five have issued a Buy rating, four have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Hold” and an average price target of $72.85.
Read Our Latest Research Report on LQDA
Liquidia Company Profile
Liquidia Corporation is a biopharmaceutical company focused on developing and commercializing therapies for patients with pulmonary hypertension and other serious cardiopulmonary diseases. The company is headquartered in Research Triangle Park, North Carolina, and uses its proprietary PRINT technology to engineer drug particles with controlled size, shape and composition for inhaled and injectable medicines.
Liquidia’s lead product is Yutrepia (treprostinil) inhalation powder, a dry-powder formulation of treprostinil delivered through a proprietary inhaler.
Recommended Stories
- Five stocks we like better than Liquidia
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.
